Data / Form D filings / Biophytis SA
Biophytis SA: Form D filings
Biophytis SA, a biotechnology company in Paris, France, filed 2 Form D notices with the SEC in 2026. The latest, on September 23, 2026, reports $2.6 million sold of a $2.6 million offering to 3 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 14 avenue de l'Opera, Paris, France, 75001
- Phone
- +33 1 44 37 23 00
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- France
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1768946
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 23, 2026 | New notice | $2,598,526 | $2,598,526 | 3 | Sep 15, 2026 | sec.gov | |
| Mar 23, 2026 | New notice | $1,584,275 | $1,584,275 | 3 | Mar 13, 2026 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Stanislas Veillet | Executive Officer, Director | |
| Claude Allary | Director | |
| Nadine Coulm | Director | |
| Jean Mariani | Executive Officer, Director | |
| Christophe Courtillat | Executive Officer | |
| Edouard Bieth | Executive Officer | |
| Chiara Baccelli | Executive Officer | |
| Pierre Dilda | Executive Officer | |
| Waly Dioh | Executive Officer |
Every Form D from the week of Sep 21, 2026 · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Biophytis SA reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.